SMS Lifesciences India Limited (SMSLIFE.NS)
INR 1133.7
(1.45%)
INR 1133.7
(1.45%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 812.1 Million INR | 0.93% |
| 2022 | 804.62 Million INR | -5.13% |
| 2021 | 848.11 Million INR | 37.61% |
| 2020 | 616.31 Million INR | -4.15% |
| 2019 | 642.98 Million INR | -20.78% |
| 2018 | 811.67 Million INR | 64.59% |
| 2017 | 493.16 Million INR | 12.61% |
| 2016 | 437.94 Million INR | 4.68% |
| 2015 | 418.35 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 812.1 Million INR | 0.93% |
| 2023 Q4 | 812.1 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 733.42 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 781.79 Million INR | 0.0% |
| 2022 FY | 804.62 Million INR | -5.13% |
| 2022 Q4 | 804.62 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q2 | 729.64 Million INR | 0.0% |
| 2021 Q4 | 848.11 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 848.11 Million INR | 37.61% |
| 2020 Q2 | 536.54 Million INR | 0.0% |
| 2020 FY | 616.31 Million INR | -4.15% |
| 2020 Q4 | 616.31 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 606.79 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 642.98 Million INR | -20.78% |
| 2019 Q4 | 642.98 Million INR | 0.0% |
| 2018 FY | 811.67 Million INR | 64.59% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 811.67 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 803.93 Million INR | 0.0% |
| 2017 FY | 493.16 Million INR | 12.61% |
| 2017 Q2 | 594.32 Million INR | 0.0% |
| 2017 Q4 | 493.16 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 FY | 437.94 Million INR | 4.68% |
| 2016 Q4 | 437.94 Million INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 FY | 418.35 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Biocon Limited | 49.43 Billion INR | 98.357% |
| Blue Jet Healthcare Limited | 1.29 Billion INR | 37.451% |
| Concord Biotech Limited | 2.07 Billion INR | 60.948% |
| Dishman Carbogen Amcis Limited | 8.82 Billion INR | 90.802% |
| Jubilant Ingrevia Limited | 9.41 Billion INR | 91.373% |
| Lyka Labs Limited | 95.71 Million INR | -748.434% |
| Panacea Biotec Limited | 1.77 Billion INR | 54.361% |
| Piramal Pharma Limited | 21.75 Billion INR | 96.268% |
| Supriya Lifescience Limited | 852.49 Million INR | 4.737% |
| Syngene International Limited | 2.38 Billion INR | 65.95% |
| TAKE Solutions Limited | 7.96 Million INR | -10102.312% |
| Zota Health Care Limited | 537.66 Million INR | -51.044% |